Pharmaceutical development of co-crystals
Co-crystals are solids that are crystalline materials composed of two or more molecules in the same crystal lattice. Formation of co-crystals can solve several pharmaceutical issues raised during preformulation and formulation development e.g. by solubility, dissolution, bioavailability, chemical st...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Dissertation |
| Published: |
2012-07-02
|
| Subjects: | |
| doi: | 10.14232/phd.1454 |
| mtmt: | 2241557 |
| Online Access: | http://doktori.ek.szte.hu/1454 |
| Summary: | Co-crystals are solids that are crystalline materials composed of two or more molecules in the same crystal lattice. Formation of co-crystals can solve several pharmaceutical issues raised during preformulation and formulation development e.g. by solubility, dissolution, bioavailability, chemical stability, decreasing hygroscopicity modulation. Formation of co-crystals could be a new path to improve physico-chemical and biopharmaceutical properties of medicines. One of the most difficult pharmaceutical formulation tasks is to improve the absorption of a weak base with poor and pH-dependent solubility properties; however, some combined chemical and formulation approaches give the possibility to reach this goal. Usually applied chemical tools are the salt and/or co-crystal formation, while the pharmaceutical approaches are micronization, nanonization, and elaboration of lipidic and amorphous formulations. However, to reach the targeted pharmacokinetic/pharmacodynamic (PK/PD) profiles, synergies of different chemical and pharmaceutical tools are needed. |
|---|---|
| Physical Description: | 1101 |